Current
0.5×
5-Year Average
0.6×
All-Time High
1.7×
All-Time Low
0.3×
P/S Ratio daily chart for Elevance Health (ELV)
Jun 8, 2021 – Jun 5, 2026 · 1,255 trading days
Historical P/S Ratio for Elevance Health (ELV) from 2002 to 2025
| 2025 | $77.75B | $199.13B | 0.4× | -0.1× | |
| 2024 | $83.92B | $176.81B | 0.5× | -0.2× | |
| 2023 | $109.91B | $171.34B | 0.6× | -0.1× | |
| 2022 | $122.07B | $156.59B | 0.8× | -0.0× | |
| 2021 | $112.07B | $138.64B | 0.8× | +0.2× | |
| 2020 | $78.80B | $121.87B | 0.6× | -0.1× | |
| 2019 | $76.39B | $104.21B | 0.7× | -0.0× | |
| 2018 | $67.59B | $92.11B | 0.7× | +0.1× | |
| 2017 | $57.62B | $90.04B | 0.6× | +0.2× | |
| 2016 | $37.92B | $84.89B | 0.4× | -0.0× | |
| 2015 | $36.43B | $79.16B | 0.5× | +0.0× | |
| 2014 | $33.50B | $73.87B | 0.5× | +0.1× | |
| 2013 | $26.05B | $70.69B | 0.4× | +0.1× | |
| 2012 | $18.47B | $61.71B | 0.3× | -0.1× | |
| 2011 | $21.98B | $60.71B | 0.4× | +0.0× | |
| 2010 | $20.96B | $58.72B | 0.4× | -0.0× | |
| 2009 | $25.71B | $65.03B | 0.4× | +0.1× | |
| 2008 | $20.90B | $61.25B | 0.3× | -0.4× | |
| 2007 | $47.77B | $61.16B | 0.8× | -0.1× | |
| 2006 | $48.14B | $57.01B | 0.8× | -0.3× | |
| 2005 | $52.13B | $44.68B | 1.2× | -0.5× | |
| 2004 | $35.22B | $20.82B | 1.7× | +1.1× | |
| 2003 | $10.36B | $16.77B | 0.6× | -0.0× | |
| 2002 | $8.74B | $13.28B | 0.7× | — |
- 20250.4×
- 20240.5×
- 20230.6×
- 20220.8×
- 20210.8×
- 20200.6×
- 20190.7×
- 20180.7×
- 20170.6×
- 20160.4×
- 20150.5×
- 20140.5×
- 20130.4×
- 20120.3×
- 20110.4×
- 20100.4×
- 20090.4×
- 20080.3×
- 20070.8×
- 20060.8×
- 20051.2×
- 20041.7×
- 20030.6×
- 20020.7×
About P/S Ratio at Elevance Health (ELV)
Elevance Health (ELV) P/S ratio is 0.5× as of June 5, 2026. The 5-year average is 0.6×. The sector median currently stands at 3.5×. The current ratio is at the 19th percentile of its own 10-year history.
Elevance Health (ELV) historical P/S ratio has ranged from a low of 0.3× (2002) to a high of 1.7× (2004) in the available daily series.
The price-to-sales (P/S) ratio compares a company's market capitalisation to its trailing twelve-month (TTM) revenue. It is calculated as market cap ÷ TTM revenue (equivalent to share price ÷ TTM revenue per share). Because the denominator (revenue) cannot be negative, P/S is widely used to value unprofitable or pre-profit companies and to make cross-sector comparisons.
Elevance Health P/S Ratio by Year
Elevance Health P/S Ratio 2025: 0.4×
Elevance Health (ELV) P/S ratio in 2025 was 0.4×, contracted from 0.5× the prior year.
Elevance Health P/S Ratio 2024: 0.5×
Elevance Health (ELV) P/S ratio in 2024 was 0.5×, contracted from 0.6× the prior year.
Elevance Health P/S Ratio 2023: 0.6×
Elevance Health (ELV) P/S ratio in 2023 was 0.6×, contracted from 0.8× the prior year.
Elevance Health P/S Ratio 2022: 0.8×
Elevance Health (ELV) P/S ratio in 2022 was 0.8×, contracted from 0.8× the prior year.
Elevance Health P/S Ratio 2021: 0.8×
Elevance Health (ELV) P/S ratio in 2021 was 0.8×.
Sector peers by P/S Ratio — chart
Current ratio vs. sector peers. Highlighted bar is this company.
Sector peers by P/S Ratio — table
Healthcare peers of Elevance Health (ELV), ranked by P/S ratio.
| 2.5× | |
| 2.1× | |
| 2.1× | |
| 2.1× | |
| 1.9× | |
| 1.9× | |
| 1.7× | |
| 1.6× | |
| 1.6× | |
| 1.4× | |
| 1.4× | |
| 1.1× | |
| 0.8× | |
| 0.7× | |
| 0.6× | |
| 0.6× | |
| 0.5× | |
| 0.3× | |
| 0.3× | |
| 0.2× | |
| 0.2× | |
| 0.2× | |
| 0.2× | |
| 0.2× | |
| 0.1× |
- 2.5×
- 2.1×
- 1.7×
- 1.4×
- 1.1×
- 0.7×
- 0.3×
- 0.3×
- 0.2×
- 0.2×
- 0.2×
- 0.1×
Frequently asked questions
Elevance Health (ELV) Key Financials
Charts, filings, and peer comparison for every metric